Row

A. IraqVACC

3.56 AU to center | GMT: 21 | 50 detectable titers

B. VC-VietnamVACC

2.60 AU to center | GMT: 32 | 78 detectable titers

Row

C. VC-IndonesiaVACC

0.80 AU to center | GMT: 36 | 80 detectable titers

D. VC-AnhuiVACC

1.66 AU to center | GMT: 43 | 82 detectable titers

Row

Data S6. Merged antibody profiles upon vaccination with whole-inactivated vaccines containing engineered HA antigens. An interactive version of the antibody profiles displayed in Fig. 2. For each HA vaccine antigen, the position, breadth, and height of a mean merged serum per group (n=6) are represented in the antigenic map from Fig. 1B. HA present in vaccine: (A) IraqVACC, (B) CVA-VietnamVACC, (C) CVA-IndonesiaVACC, (D) CVA-AnhuiVACC. Representation is as described for Fig. 2. In addition, the map orientation can be changed by clicking and dragging within the visualization, and scrolling allows zooming in and out. Antigen names can be visualized by hovering over the points. GMT: geometric mean titer.